Early Diagnostic Biomarkers for Esophageal Adenocarcinoma—The Current State of Play
- 1 July 2013
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 22 (7) , 1185-1209
Abstract
Esophageal adenocarcinoma (EAC) is one of the two most common types of esophageal cancer with alarming increase in incidence and very poor prognosis. Aiming to detect EAC early, currently high-risk patients are monitored using an endoscopic-biopsy approach. However, this approach is prone to sampling error and interobserver variability. Diagnostic tissue biomarkers related to genomic and cell-cycle abnormalities have shown promising results, although with current technology these tests are difficult to implement in the screening of high-risk patients for early neoplastic changes. Differential miRNA profiles and aberrant protein glycosylation in tissue samples have been reported to improve performance of existing tissue-based diagnostic biomarkers. In contrast to tissue biomarkers, circulating biomarkers are more amenable to population-screening strategies, due to the ease and low cost of testing. Studies have already shown altered circulating glycans and DNA methylation in BE/EAC, whereas disease-associated changes in circulating miRNA remain to be determined. Future research should focus on identification and validation of these circulating biomarkers in large-scale trials to develop in vitro diagnostic tools to screen population at risk for EAC development. Cancer Epidemiol Biomarkers Prev; 22(7); 1185–209. ©2013 AACR.Keywords
This publication has 198 references indexed in Scilit:
- The microRNAs, MiR‐31 and MiR‐375, as candidate markers in Barrett's esophageal carcinogenesisGenes, Chromosomes and Cancer, 2012
- Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal AdenocarcinomaJournal of Gastrointestinal Surgery, 2012
- Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinomaGenes, Chromosomes and Cancer, 2011
- MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal AdenocarcinomaThe Annals of Thoracic Surgery, 2011
- Prognostic significance of differentially expressed miRNAs in esophageal cancerInternational Journal of Cancer, 2010
- Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomasCancer, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinomaElectrophoresis, 2010
- Chromosomal abnormalities and novel disease‐related regions in progression from Barrett's esophagus to esophageal adenocarcinomaInternational Journal of Cancer, 2009
- MicroRNA expression profiles of esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 2008